JP Morgan Conference 2017

On Tuesday January 10th at 9am PST, Patrick Vallance, GSK’s President, R&D, gives the company’s presentation to investors.

The 35th annual J.P. Morgan Healthcare Conference, held in San Francisco, USA, brings together global industry leaders, healthcare technology companies, service providers and members of the investment community. In 2017 more than 400 companies, both public and private, are expected, delivering presentations to more than 4,000 investors. 

Patrick Vallance

Dr Patrick Vallance, President, R&D, joined GSK in May 2006 as Head of Drug Discovery. He is also a member of the Board and the Corporate Executive Team. Read his full bio.

 

 

 

 

Conference materials

Recent pipeline press releases

ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention

20 December 2016

GSK starts phase III study of once-daily closed triple combination therapy FF/UMEC/VI in patients with asthma

19 December 2016

ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen

19 December 2016

GSK submits regulatory application in Japan for belimumab in systemic lupus erythematosus

13 December 2016

Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD

02 December 2016